AlphaYou
Overview
8 funds hold it, insiders have been net selling, and 11 straight earnings beats.
Key stats
Sep 7- Open
- $1,031.09
- 52-wk high
- $1,148.37
- High
- $1,041.20
- 52-wk low
- $719.42
- Low
- $1,024.63
- Prev close
- $1,037.93
- Mkt cap
- $302.41B
- P/E
- 16.0x
- Volume
- 1.43M
- Fwd P/E
- 14.0x
- Beta
- 1.28
- Div yield
- 1.64%
- P/S
- 4.5x
- P/B
- 2.8x
- Profit margin
- +31.0%
- Op margin
- +42.2%
- ROE
- +16.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in 45.0% above what analysts expected.
Earnings per share
$14.47 expected
Reports Oct 13, 2026, in 36 days
EPS expected
$12.69 to $18.98
Revenue expected
14 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $32.15B | $30.13B | $17.23B | $38.43B |
| Cost of what it sold | $17.31B | $14.55B | $315.0M | $18.20B |
| Gross profit | $14.85B | $15.58B | $16.91B | $20.24B |
| What it spent | ||||
| Sales and admin | $4.68B | $4.67B | $7.44B | $7.58B |
| Other operating costs | $4.77B | $5.06B | $2.99B | $1.13B |
| Total operating expenses | $9.45B | $9.72B | $10.43B | $8.71B |
| What was left | ||||
| Operating profit | $5.39B | $5.86B | $6.49B | $11.52B |
| Interest on debt | $16.97B | $16.67B | $17.08B | $18.09B |
| Profit before tax | $5.39B | $5.86B | $6.49B | $8.56B |
| Tax | $1.29B | $1.24B | $856.0M | $1.94B |
| Net profit | $4.10B | $4.62B | $5.63B | $6.63B |
| EBITDA | $5.92B | $6.38B | $7.05B | $12.03B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
AFM discloses Goldman Sachs’ 2.91% stake in Qiagen
NeutralSep 4Can TROW's New Securitized Income ETF Boost Fixed-Income Growth?
Leans bullishSep 4Ultrapar Participacoes (NYSE:UGP) Price Target Raised to $7.90
Leans bearishSep 4Amgen (AMGN) Says Repatha Reduced Mortality Before a First Heart Attack or Stroke. Can Earlier Use Expand the Market?
NeutralSep 4Van ECK Associates Corp Has $3.49 Million Holdings in Ambev S.A. $ABEV
Leans bullishSep 4Goldman Sachs Adjusts Price Target on Equifax to $199 From $182, Keeps Neutral Rating
NeutralSep 4XML Financial LLC Purchases Shares of 5,177 The Goldman Sachs Group, Inc. $GS
Leans bullishSep 4Public Employees Retirement System of Ohio Invests $3.63 Million in Elbit Systems Ltd. $ESLT
NeutralSep 4